Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death

Cell Death and Differentiation

Volumn 8, Issue 12, 2001, Pages 1169-1181

  Henshall, D C ^a   Bonislawski, D P ^a   Skradski, S L ^a   Araki, T ^a   Lan, J Q ^a   Schindler, C K ^a   Meller, R ^a   Simon, R P ^a  

^a Legancy Research   (United States)

Author keywords

Apoptosis; bcl 2; Brain; CED 4; Epilepsy; Kainic acid; Mitochondria; Necrosis; Programmed cell death

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; ASPARAGINE; CASPASE 9; CYTOCHROME C; DNA FRAGMENT; GLUTAMINE; HISTIDINE; KAINIC ACID; KETONE DERIVATIVE; LEUCINE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; IN VIVO STUDY; MICROINJECTION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TARGETING; RAT; SEIZURE;

ANIMALS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BRAIN; CASPASE 9; CASPASES; CELL DEATH; CYTOCHROME C GROUP; DNA FRAGMENTATION; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MACROMOLECULAR SUBSTANCES; NEURONS; OLIGOPEPTIDES; PROTEINS; RATS; SEIZURES;

ANIMALIA;

EID: 0035670146     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400921     Document Type: Article

References (64)

1. Apoptosis in neurological disease
2. Caspases: Enemies within
3. Caspases as treatment targets in stroke and neurodegenerative diseases
4. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B
5. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
6. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia
7. Caspases: Their intracellular localization and translocation during apoptosis
8. Apaf-1, a human protein homologous to c. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
9. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
10. Solution structure of Apaf-1 CARD and its interaction with caspase-9 CARD: A structural basis for specific adaptor/caspase interaction
11. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes
12. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis
13. Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1
14. Caspase-9 and APAF-1 form an active holoenzyme
15. Differential requirement for caspase 9 in apoptotic pathways in vivo
16. Apaf1 and the apoptotic machinery
17. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
18. Kainate-induced apoptotic cell death in hippocampal neurons
19. Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat
20. Kainic acid-induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNA cleavage: Implications for programmed cell death mechanisms
21. Seizure-induced neuronal necrosis: Implications for programmed cell death mechanisms
22. Activation of CPP32 protease in hippocampal neurons following ischemia and epilepsy
23. Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment
24. Differential c-Fos and caspase expression following kainic acid excitotoxicity
25. Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizures
26. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy
27. Caspase-2 activation is redundant during seizure-induced neuronal death
28. Intracellular calcium accumulation in rat hippocampus during seizures induced by bicuculline or L-allylglycine
29. Status epilepticus: The reversibility of calcium loading and acute neuronal pathological changes in the rat hippocampus
30. Spatio-temporal profile of DNA fragmentation and its relationship to patterns of epileptiform activity following focally evoked limbic seizures
31. Injections of kainic acid into the amygdaloid complex of the rat: An electrographic, clinical and histological study in relation to the pathology of epilepsy
32. Relationship between seizure-induced transcription of the DNA damage-inducible gene GADD45, DNA fragmentation and neuronal death in focally evoked limbic epilepsy
33. Cell damage in epilepsy and the role of calcium in cytotoxicity
34. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor
35. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis
36. Death receptors: Signaling and modulation
37. Apoptosis control by death and decoy receptors
38. Mitochondria and apoptosis
39. Survival- and death-promoting events after transient cerebral ischemia: Phosphorylation of Akt, release of cytochrome C and activation of caspase-like proteases
40. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice
41. Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c
42. Apoptosis driven by IP(3)-linked mitochondrial calcium signals
43. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity
44. The role of glutamate in epilepsy and other CNS disorders
45. Characterization of the rat DNA fragmentation factor 35/Inhibitor of caspase-activated DNase (Short form)
46. Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-x(L)
47. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes
48. Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death
49. The ’harmless’ release of cytochrome c
50. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation
51. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB
52. An alternative, nonapoptotic form of programmed cell death
53. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis- inducing ligand mediate ischemia-induced apoptosis in neurons
54. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat
55. Intracerebral injection of caspase-3 inhibitor prevents neuronal apoptosis after kainic acid-evoked status epilepticus
56. Apoptosis: Cell death defined by caspase activation
57. Caspases and apoptosis-biology and terminology
58. Caspase-independent programmed cell death with necrotic morphology
59. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy
60. Do nonconvulsive seizures damage the brain?-No
61. Do nonconvulsive seizures damage the brain?- Yes
62. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy
63. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy